Acne Procedural denied as experimental or investigational by Humana?

Humana's specific coverage criteria for acne procedural are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Denied Acne Procedural Treatment as Experimental

Humana's "experimental or investigational" denial means its medical policy team has determined that the requested acne procedure lacks sufficient evidence in the published literature to meet Humana's clinical coverage standard. This designation is applied when a technology, device, or technique is newer, lacks large controlled trial evidence in Humana's policy criteria, or when the specific indication (e.g., a particular acne subtype or severity level) falls outside the procedure's established coverage criteria.

## Why This Denial Is Appealable

Many acne procedural modalities — including certain laser, light-based, and chemical procedures — have substantial peer-reviewed support and are endorsed by major dermatology societies even if a specific insurer's policy has not yet been updated to reflect that evidence. An "experimental" designation is a clinical determination, which means it is subject to independent external review, not just an administrative appeal. External reviewers often disagree with insurer experimental classifications, making this one of the most winnable denial types at the IRO level.

## Federal Appeal Framework

• Internal appeal: File under ERISA §503 or ACA §2719. Experimental denials are clinical determinations — make sure your appeal includes a physician-authored rebuttal, not just administrative paperwork.
• External review: Because this is a medical-judgment denial, you have the right to independent external review by an accredited IRO. The window is generally up to four months from the final internal denial. Expedited review (72-hour turnaround) is available when delay would seriously jeopardize your health. IROs overturn experimental denials at a meaningful rate.
• Request Humana's evidence criteria — Humana must disclose the specific clinical criteria and evidence standards its reviewers used. Request this information in writing as part of your appeal.

## Documentation to Gather

1. Dermatologist's medical-necessity letter — A detailed letter from your treating dermatologist citing peer-reviewed literature and AAD guidelines that support the procedure's safety and efficacy for your specific indication. 2. Peer-reviewed literature — Published studies or systematic reviews supporting the procedure. Your dermatologist's office or a medical librarian can assist with retrieval. 3. AAD or specialty-society position statements — Any published guideline or position statement from the American Academy of Dermatology that addresses the procedure's appropriateness. 4. Humana's clinical policy — Obtain Humana's exact coverage policy and the evidence criteria applied. Your appeal should address each criterion directly. 5. Your clinical records — Diagnosis documentation, severity assessment, and treatment history showing that the procedure is appropriate for your presentation.

## Criteria-Mapping Structure

List each criterion Humana used to classify the procedure as experimental. For each, provide: (a) the published evidence or guideline that supports efficacy, and (b) the specific chart fact showing your case falls within the studied population. A physician co-signing the appeal letter materially increases the credibility of this rebuttal.